The aim of the study was to analyze the prevalence and association of recurrent founder germline mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 genes with ovarian cancer risk among unselected patients in the Polish population. This evidence concerns the gene RAD51C and ovarian carcinoma.